吴树彬;陈唯韫;黄宇光;
WU Shu-bin;CHEN Wei-yun;HUANG Yu-guang;Department of Anesthesiology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院麻醉科

摘要(Abstract)：

输血相关性急性肺损伤(transfusion-related acute lung injury,TRALI)是输血导致死亡的首要原因,但临床缺乏有效的防治手段,了解其病理生理机制有助于更有效地预防TRALI。根据介导因子不同,可将其分为抗体介导(免疫性)和非抗体介导(非免疫性)TRALI;前者主要由被动输注内源性抗体导致,后者主要由血制品中的可溶性分子和某些细胞成分介导。本文旨在对非抗体介导TRALI的发病机制及研究现状进行综述,为临床工作提供理论指导。
Transfusion related acute lung injury( TRALI) is a leading cause of transfusion related death.It is helpful to prevent and cure TRALI by understanding the potential mechanism of TRALI. Based on causative factors,it is divided into antibody mediated TRALI and non-antibody mediated TRALI; the former is caused by the passively infused endogenous antibodies,and the latter is mediated by the soluble molecules andcellular components from blood products. This review focuses on mechanisms of non-antibody mediated TRALI which include biological response modifiers accumulating during storage of red blood cells( RBCs) and platelets( PLTs),as well as changes in morphology and function of aged PLTs and RBCs,and the current research progress,so as to provide theoretical direction for clinical practice.

关键词(KeyWords)： 输血相关性急性肺损伤;生物反应调节因子;输血
transfusion related acute lung injury;biological response modifier;blood transfusion

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金青年科学基金(81400049)

作者(Author): 吴树彬;陈唯韫;黄宇光;
WU Shu-bin;CHEN Wei-yun;HUANG Yu-guang;Department of Anesthesiology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

Email:

DOI:

参考文献(References)：

• [1]Clifford L,Jia Q,Subramanian A,et al.Characterizing theepidemiology of postoperative transfusion-related acute lung injury[J].Anesthesiology,2015,122:12-20.
• [2]Benson AB,Austin GL,Berg M,et al.Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding[J].Intensive Care Med,2010,36:1710-1717.
• [3]Toy P,Gajic O,Bacchetti P,et al.Transfusion-related acute lung injury:incidence and risk factors[J].Blood,2012,119:1757-1767.
• [4]Mangalmurti NS,Xiong Z,Hulver M,et al.Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation[J].Blood,2009,113:1158-1166.
• [5]Zhi L,Chi X,Gelderman MP,et al.Activation of platelet protein kinase C by ultraviolet light B mediates platelet transfusion-related acute lung injury in a two-event animal model[J].Transfusion,2013,53:722-731.
• [6]Caudrillier A,Kessenbrock K,Gilliss BM,et al.Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury[J].J Clin Invest,2012,122:2661-2671.
• [7]Looney MR,Nguyen JX,Hu Y,et al.Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury[J].J Clin Invest,2009,119:3450-3461.
• [8]Ortiz-Mu1oz G,Mallavia B,Bins A,et al.Aspirintriggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice[J].Blood,2014,124:2625-2634.
• [9]Chi X,Zhi L,Vostal JG.Human platelets pathogen reduced with riboflavin and ultraviolet light do not cause acute lung injury in a two-event SCID mouse model[J].Transfusion,2014,54:74-85.
• [10]Tuinman PR,Vlaar AP,Binnenkade JM,et al.The effect of aspirin in transfusion-related acute lung injury in critically ill patients[J].Anaesthesia,2012,67:594-599.
• [11]Hechler B,Maitre B,Magnenat S,et al.Platelets are dispensable for antibody-mediated transfusion-related acute lung injury in the mouse[J].J Thromb Haemost,2016,14:1255-1267.
• [12]Blumberg N,Gettings KF,Turner C,et al.An association of soluble CD40 ligand(CD154)with adverse reactions to platelet transfusions[J].Transfusion,2006,46:1813-1821.
• [13]Khan SY,Kelher MR,Heal JM,et al.Soluble CD40 ligand accumulates in stored blood components,primes neutrophils through CD40,and is a potential cofactor in the development of transfusion-related acute lung injury[J].Blood,2006,108:2455-2462.
• [14]Tung JP,Fung YL,Nataatmadja M,et al.A novel in vivo ovine model of transfusion-related acute lung injury[J].Vox Sang,2011,100:219-230.
• [15]Tuinman PR,Gerards MC,Jongsma G,et al.Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury[J].Clin Exp Immunol,2011,165:278-284.
• [16]Peters AL,Vervaart MA,van Bruggen R,et al.Non-polar lipids accumulate during storage of transfusion products and do not contribute to the onset of transfusion-related acute lung injury[J].Vox Sang,2017,112:25-32.
• [17]Silliman CC,Bjornsen AJ,Wyman TH,et al.Plasma and lipids from stored platelets cause acute lung injury in an animal model[J].Transfusion,2003,43:633-640.
• [18]Kelher MR,Masuno T,Moore EE,et al.Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model[J].Blood,2009,113:2079-2087.
• [19]Vlaar AP,Hofstra JJ,Kulik W,et al.Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model[J].Blood,2010,116:1360-1368.
• [20]Vlaar AP,Hofstra JJ,Determann RM,et al.The incidence,risk factors,and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients:a prospective nested case-control study[J].Blood,2011,117:4218-4225.
• [21]Gajic O,Yilmaz M,Iscimen R,et al.Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components[J].Crit Care Med,2007,35:1645-1648.
• [22]Maslanka K,Uhrynowska M,Lopacz P,et al.Analysis of leucocyte antibodies,cytokines,lysophospholipids and cell microparticles in blood components implicated in post-transfusion reactions with dyspnoea[J].Vox Sang,2015,108:27-36.
• [23]Blumberg N,Heal JM,Gettings KF,et al.An association between decreased cardiopulmonary complications(transfusion-related acute lung injury and transfusion-associated circulatory overload)and implementation of universal leukoreduction of blood transfusions[J].Transfusion,2010,50:2738-2744.
• [24]Sugawara A,Nollet KE,Yajima K,et al.Preventing plateletderived microparticle formation—and possible side effects with prestorage leukofiltration of whole blood[J].Archpathol lab med,2010,134:771-775.
• [25]Kent MW,Kelher MR,West FB,et al.The pro-inflammatory potential of microparticles in red blood cell units[J].Transfusmed,2014,24:176-181.
• [26]Xie RF,Hu P,Li W,et al.The effect of platelet-derivedmicroparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst[J].Vox Sang,2014,106:234-241.
• [27]Xie RF,Hu P,Wang ZC,et al.Platelet-derived microparticles induce polymorphonuclear leukocyte-mediated damage of human pulmonary microvascular endothelial cells[J].Transfusion,2015,55:1051-1057.
• [28]Bennett-Guerrero E,Kirby BS,Zhu H,et al.Randomized study of washing 40-to 42-day-stored red blood cells[J].Transfusion,2014,54:2544-2552.
• [29]Flesland O.A comparison of complication rates based on published haemovigilance data[J].Intensive Care Med,2007,33:S17-21.
• [30]Sowemimo-Coker SO.Evaluation of an experimental filter designed for improving the quality of red blood cells(RBCs)during storage by simultaneously removing white blood cells and immunomodulators and improving RBC viscoelasticity and Band 3 proteins[J].Transfusion,2014,54:592-601.
• [31]Silliman CC,Kelher MR,Khan SY,et al.Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo[J].Blood,2014,123:3488-3495.
• [32]Wang D,Sun J,Solomon SB,et al.Transfusion of older stored blood and risk of death:a meta-analysis[J].Transfusion,2012,52:1184-1195.
• [33]Vlaar AP,Straat M,Juffermans NP.The relation between aged blood products and onset of transfusion-related acute lung injury.A review of pre-clinical data[J].Clin Lab,2011,57:267-272.